Correlation of marrow iron patterns with disease status of chronic myelogenous leukemia

J L Welborn1, J P Lewis

  • 1Department of Internal Medicine and Pathology, University of California, Davis, Sacramento 95817.

Leukemia & Lymphoma
|August 1, 1993
PubMed

Insights

Iron levels in bone marrow can indicate chronic myelogenous leukemia (CML) progression. A switch to positive iron staining signals the accelerated phase of CML, offering a prognostic indicator for disease evolution.

Area of Science:

  • Hematology
  • Oncology
  • Medical Diagnostics

Background:

  • Most chronic myelogenous leukemia (CML) patients in the stable phase exhibit absent bone marrow iron despite normal iron levels.
  • Serum iron, total iron binding capacity, and serum ferritin are typically normal in stable CML.

Purpose of the Study:

  • To investigate the pattern of bone marrow iron staining in patients with Philadelphia chromosome-positive CML.
  • To determine if bone marrow iron patterns serve as a prognostic indicator for CML disease evolution.

Main Methods:

  • Analysis of 187 bone marrow aspirates from 67 patients with Philadelphia chromosome-positive CML.
  • Evaluation of CML patients across chronic, accelerated, and blast crisis stages.
  • Sequential bone marrow aspirates from 30 patients to track iron status changes over time.

Main Results:

  • A significant proportion of stable phase CML patients (over 80%) showed no detectable marrow iron.
  • The transition from negative to positive bone marrow iron staining was observed to coincide with the development of the accelerated phase or blast crisis of CML.
  • Sequential analysis confirmed the temporal relationship between iron status switch and disease progression.

Conclusions:

  • Bone marrow iron staining patterns are a valuable prognostic indicator in chronic myelogenous leukemia.
  • Monitoring bone marrow iron can aid in predicting CML disease evolution and identifying critical transition points.